BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 16545538)

  • 1. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
    Vickers AE; Bentley P; Fisher RL
    Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.
    Vickers AE
    Toxicol Pathol; 2009 Jan; 37(1):78-88. PubMed ID: 19234235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
    van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
    Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status.
    Vendemiale G; Grattagliano I; Caraceni P; Caraccio G; Domenicali M; Dall'Agata M; Trevisani F; Guerrieri F; Bernardi M; Altomare E
    Hepatology; 2001 Apr; 33(4):808-15. PubMed ID: 11283843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
    Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
    Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of mitochondrial fatty acid oxidation and hepatic gene expression by catecholamine.
    Barke RA; Brady PS; Brady LJ
    J Surg Res; 1993 Feb; 54(2):95-101. PubMed ID: 8479178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
    Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
    Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
    Serviddio G; Bellanti F; Giudetti AM; Gnoni GV; Petrella A; Tamborra R; Romano AD; Rollo T; Vendemiale G; Altomare E
    J Pharmacol Exp Ther; 2010 Mar; 332(3):922-32. PubMed ID: 20008062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of bovine hepatic fatty acid oxidation.
    Jesse BW; Emery RS; Thomas JW
    J Dairy Sci; 1986 Sep; 69(9):2290-7. PubMed ID: 3782585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
    Soto A; DelRaso NJ; Schlager JJ; Chan VT
    Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
    Hong J; Jeppesen PB; Nordentoft I; Hermansen K
    Diabetes Metab Res Rev; 2007 Mar; 23(3):202-10. PubMed ID: 16802400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver.
    Catalá A; Zvara A; Puskás LG; Kitajka K
    J Pineal Res; 2007 Jan; 42(1):43-9. PubMed ID: 17198537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress.
    Lluis JM; Colell A; García-Ruiz C; Kaplowitz N; Fernández-Checa JC
    Gastroenterology; 2003 Mar; 124(3):708-24. PubMed ID: 12612910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
    Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.